ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.9368
0.10%
Brent Oil
84.015
0.54%
Bitcoin
61,395.46
0.34%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Eyegate Pharmaceuticals Inc (EYEGW)

  7. Eyegate Pharmaceuticals Inc (EYEGW) Noticias

EYEGW

Eyegate Pharmaceuticals (EYEGW)

Eyegate Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EYEGW
FechaHoraFuenteTítuloSímboloCompañía
21/09/201607:30GlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
13/09/201607:30GlobeNewswire Inc.EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of DefenseNASDAQ:EYEGWEyegate Pharmaceuticals Inc
12/09/201607:30GlobeNewswire Inc.EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/09/201607:30GlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
10/08/201615:50GlobeNewswire Inc.EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
01/08/201607:30GlobeNewswire Inc.EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammat...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
30/06/201612:00GlobeNewswire Inc.EyeGate Announces Completion of $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
27/06/201607:00GlobeNewswire Inc.EyeGate Announces $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
01/06/201607:30GlobeNewswire Inc.EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation an...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
24/05/201617:00GlobeNewswire Inc.EyeGate Pharma Announces At The Market Issuance ProgramNASDAQ:EYEGWEyegate Pharmaceuticals Inc
13/05/201616:25GlobeNewswire Inc.Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/05/201607:30GlobeNewswire Inc.EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and DevelopmentNASDAQ:EYEGWEyegate Pharmaceuticals Inc
28/04/201610:46GlobeNewswire Inc.EyeGate Pharma to Present Four Posters at ARVO 2016 Annual Meeting Supporting Development of CMHA-SNASDAQ:EYEGWEyegate Pharmaceuticals Inc
27/04/201615:05GlobeNewswire Inc.EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial OfficerNASDAQ:EYEGWEyegate Pharmaceuticals Inc
29/03/201615:45GlobeNewswire Inc.EyeGate Reports Full-year 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
09/03/201618:46GlobeNewswire Inc.EyeGate Pharma Acquires Jade TherapeuticsNASDAQ:EYEGWEyegate Pharmaceuticals Inc
09/03/201618:46GlobeNewswire Inc.EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
19/01/201607:30GlobeNewswire Inc.EyeGate Pharma Enrolls First Patient in Confirmatory Phase 3 Clinical Trial EGP-437-006 for Non-Infectious Anterior UveitisNASDAQ:EYEGWEyegate Pharmaceuticals Inc
14/01/201608:49GlobeNewswire Inc.Eyegate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 12th Annual Investor ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
12/11/201507:30GlobeNewswire Inc.EyeGate Reports Third Quarter 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
05/11/201507:45GlobeNewswire Inc.EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial of Iontophoretic EGP-437 Ophthalmic Solution in Macular Edem...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
15/10/201507:30GlobeNewswire Inc.EyeGate Pharma Receives USPTO Notice of Allowance for Next Generation of Proprietary Iontophoretic Delivery SystemNASDAQ:EYEGWEyegate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EYEGW

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
FX
USDMXN
US Dollar vs MXN
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
CCOM
US30
US 30
SPI
SP500
S&P 500
NYSE
BAC
Bank of America
COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados